Clinical Trial Update: Bacille Calmette-Guerin (BCG) Vaccine for Immune Protection Against Infections [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating the Bacille Calmette-Guérin (BCG) vaccine for immune protection against infections in adults with cystic fibrosis and b…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchiectasis
• Cystic Fibrosis
• Non-tuberculous Mycobacterial Infection

Drugs mentioned

• BCG vaccine (Bacillus Calmette-Guérin)

Snippet

Sponsor: Johns Hopkins University | Conditions: Cystic Fibrosis, Bronchiectasis Adult | Phase 2 | Status: COMPLETED | Results posted: 2025-02-10